ABBEY PHARMACY (SHERBORNE) LIMITED
Opportunity 72/100 (strong), bankability 67/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Consolidate lender relationships. 5 distinct lenders creates friction — refinance into single-lender structure for cleaner diligence. Most likely exit: share sale to pe / searcher (58/100).
Refinance opportunity
7 live charges · 5 lenders · oldest 20.5y
Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.
- · Oldest live charge is 20.5 years old — likely at or near maturity.
- · 5 lenders named — inter-creditor friction likely.
- · Distress signals active — lender appetite narrows.
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Average employees | — | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
Corporate timeline (37 events)Click to expand
- 2026-03-11📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-07-10📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-01-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2025-01-09📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-01-09📄change-person-director-company-with-change-dateofficers · CH01
- 2025-01-09📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2025-01-09📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-06-28📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-06-08📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-06-29📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-06-28📄accounts-with-accounts-type-dormantaccounts · AA
- 2020-06-29📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-06-25📄accounts-with-accounts-type-dormantaccounts · AA
- 2018-06-18📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-06-12📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-01-26📄accounts-with-accounts-type-dormantaccounts · AA
- 2014-05-02🔓Charge satisfied #4
- 2014-05-02🔓Charge satisfied #3
- 2014-05-02🔓Charge satisfied #2
- 2014-05-02🔓Charge satisfied #1
- 2014-05-01➕HEWITSON, Michael Raymond appointeddirector
- 2014-05-01➖WATKINS, Rachel resigneddirector
- 2014-05-01🔒Charge registered #7Lender: Santander UK PLC
- 2014-05-01🔒Charge registered #6Lender: Santander UK PLC
- 2014-05-01🔒Charge registered #5Lender: Santander UK PLC as Security Trustee for Each Group Member
- 2010-05-26🔒Charge registered #4Lender: Lloyds Tsb Bank PLC
- 2009-06-25➖WATKINS, Raymond Crawford resignedsecretary
- 2005-10-17🔒Charge registered #3Lender: Medical Finance (UK) Limited
- 2005-10-17🔒Charge registered #2Lender: Medical Finance (UK) Limited
- 2005-10-17🔒Charge registered #1Lender: Aah Pharmaceuticals LTD and Barclay Pharmaceuticals LTD
- 2005-10-16➖NORTHERN FORMATIONS LIMITED resignedcorporate-secretary
- 2003-04-14➖BIRCHENOUGH, Emma resignedsecretary
- 2003-04-14➕NORTHERN FORMATIONS LIMITED appointedcorporate-secretary
- 2002-02-01➕WATKINS, Raymond Crawford appointedsecretary
- 2001-09-24🏢Company incorporatedAs ABBEY PHARMACY (SHERBORNE) LIMITED
- 2001-09-24➕BIRCHENOUGH, Emma appointedsecretary
- 2001-09-24➕WATKINS, Rachel appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 12 years.
- secondaryStable-but-static management: Company is 25 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
1 med · 1 lowMultiple instances where a charge was satisfied and a new charge created within 6 months. Suggests active refinancing cycle.
Multiple address changes in a short period can indicate operational instability or admin disorder.
Similar companies
Active · Retail · DT postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 109 WETSUITS LTD→ 13743325 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| 1855 LIMITED→ 14125070 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 1NEXUS LTD→ 15842203 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| 20TH CENTURY DESIGN LTD→ 11917582 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| 5 STAR BODY JEWELLERY LIMITED→ 05169830 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| AARINKAN LTD→ 17071434 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ABC DESIGN & MOJI UK LTD→ 15182937 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABOCH 100 LTD→ 16863318 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACTIVE MOBILITY VEHICLES LIMITED→ 03286373 · est 1996 · no financials extracted | — | — | — | — | 29y | — | — |
| ADORA CRAFTED LTD→ 15820766 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AFTERWARDS LTD→ 11815137 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AGNI FUELS LTD→ 15191434 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 4 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| outstanding | Santander Santander UK PLC | A registered charge | 1 property | 01/05/2014 | — | |
| outstanding | Santander Santander UK PLC | A registered charge | 1 property | 01/05/2014 | — | |
| outstanding | Santander Santander UK PLC as Security Trustee for Each Group Member | A registered charge | — | 01/05/2014 | — | |
| satisfied | Lloyds Banking Group Lloyds Tsb Bank PLC | Debenture | 1 property | 26/05/2010 | 02/05/2014 | |
| satisfied | Medical Finance (UK) Medical Finance (UK) Limited | Debenture | 1 property | 17/10/2005 | 02/05/2014 | |
| satisfied | Medical Finance (UK) Medical Finance (UK) Limited | Legal charge | 1 property | 17/10/2005 | 02/05/2014 | |
| satisfied | Aah Pharmaceuticals and Barclay Pharmaceuticals Aah Pharmaceuticals LTD and Barclay Pharmaceuticals LTD | Debenture | 1 property | 17/10/2005 | 02/05/2014 |